AU7206794A - Oligomers for modulating ras oncogene - Google Patents

Oligomers for modulating ras oncogene

Info

Publication number
AU7206794A
AU7206794A AU72067/94A AU7206794A AU7206794A AU 7206794 A AU7206794 A AU 7206794A AU 72067/94 A AU72067/94 A AU 72067/94A AU 7206794 A AU7206794 A AU 7206794A AU 7206794 A AU7206794 A AU 7206794A
Authority
AU
Australia
Prior art keywords
oligomers
ras oncogene
modulating ras
modulating
oncogene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72067/94A
Inventor
David Ecker
Susan Freier
Walter Lima
Brett Monia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of AU7206794A publication Critical patent/AU7206794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • C12N2310/3181—Peptide nucleic acid, PNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU72067/94A 1993-06-11 1994-06-10 Oligomers for modulating ras oncogene Abandoned AU7206794A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7623493A 1993-06-11 1993-06-11
US076234 1993-06-11
PCT/US1994/006620 WO1994028720A1 (en) 1993-06-11 1994-06-10 Oligomers for modulating ras oncogene

Publications (1)

Publication Number Publication Date
AU7206794A true AU7206794A (en) 1995-01-03

Family

ID=22130748

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72067/94A Abandoned AU7206794A (en) 1993-06-11 1994-06-10 Oligomers for modulating ras oncogene

Country Status (2)

Country Link
AU (1) AU7206794A (en)
WO (1) WO1994028720A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536750A (en) * 1992-10-29 1996-07-16 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5576313A (en) * 1994-08-29 1996-11-19 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US7713738B2 (en) 2003-02-10 2010-05-11 Enzon Pharmaceuticals, Inc. Oligomeric compounds for the modulation of survivin expression
JP5107047B2 (en) 2004-11-09 2012-12-26 サンタリス ファーマ アー／エス LNA oligonucleotides and cancer treatment
NO2521784T3 (en) * 2010-01-04 2018-05-05

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871838A (en) * 1985-07-23 1989-10-03 The Board Of Rijks Universiteit Leiden Probes and methods for detecting activated ras oncogenes
US5087617A (en) * 1989-02-15 1992-02-11 Board Of Regents, The University Of Texas System Methods and compositions for treatment of cancer using oligonucleotides
DK51092D0 (en) * 1991-05-24 1992-04-15 Ole Buchardt OLIGONUCLEOTIDE ANALOGUE DESCRIBED BY PEN, MONOMERIC SYNTHONES AND PROCEDURES FOR PREPARING THEREOF, AND APPLICATIONS THEREOF

Also Published As

Publication number Publication date
WO1994028720A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
AU5307394A (en) Locking apparatus
AU4944093A (en) Osteosynthesis aid
AU1113695A (en) Containers
AU6084994A (en) Container object system
AU3020095A (en) Containerization system
AU7594594A (en) Slip-correcting load-clamping system
AU1072695A (en) Dressing
AU1248395A (en) Bandages
AU7577994A (en) Methods for inhibiting bone loss
AU1601799A (en) Electroconvergent cautery system
AU6472994A (en) Card
EP0631169A3 (en) Optical modulation apparatus.
AU7559894A (en) Oligomers for modulating metabolic function
AU7425594A (en) Breakout
AU1207795A (en) Signalling system
AU667580B2 (en) Line-handling block
AU5519494A (en) Radar apparatus
AU8055994A (en) Spreader
AU3458293A (en) Holder for cans or the like
AU5455596A (en) Containerization system
AU6425394A (en) Sectional-bar system
AU1802392A (en) New packaging/containerization system
AU7523794A (en) Oligomers for modulating viral processes
AU7206794A (en) Oligomers for modulating ras oncogene
AU6224194A (en) Blast-cleaning system